Accessibility: Skip TopNav
Overall Survival in Phase III SUNRISE Subgroup Receiving Subsequent Immune Checkpoint Inhibitors
Modified from Kallinteris NL et. al., AACR 2017
Format
PNG
Source
Peregrine Pharmaceuticals Inc.
Téléchargements
Original
Grand
Moyen
Petit